Vaccine manufacturer: Developed an integrated go-to-market strategy
Oliver Wyman assisted a vaccine manufacturer in developing an integrated go-to-market strategy for a new product coming out of its pipeline. Using powerful modeling techniques and competitor benchmarking, our “Sight Lines” approach simultaneously tested and optimized elements of strategy with patients, caregivers, and reimbursement plans and payers. The resulting strategy model allowed executives to predict the market and financial impact of individual tactics and competitors’ countermoves.
